These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7561062)

  • 1. Structural restriction in the heavy chain CDR3 of human rheumatoid factors.
    Børretzen M; Randen I; Natvig JB; Thompson KM
    J Immunol; 1995 Oct; 155(7):3630-7. PubMed ID: 7561062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping IgG epitopes bound by rheumatoid factors from immunized controls identifies disease-specific rheumatoid factors produced by patients with rheumatoid arthritis.
    Bonagura VR; Agostino N; Børretzen M; Thompson KM; Natvig JB; Morrison SL
    J Immunol; 1998 Mar; 160(5):2496-505. PubMed ID: 9498795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ-line gene usage.
    Børretzen M; Chapman C; Natvig JB; Thompson KM
    Eur J Immunol; 1997 Mar; 27(3):735-41. PubMed ID: 9079816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors.
    Crouzier R; Martin T; Pasquali JL
    J Immunol; 1995 May; 154(9):4526-35. PubMed ID: 7722307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid factor specificity of a VH3-encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding.
    Zhang M; Majid A; Bardwell P; Vee C; Davidson A
    J Immunol; 1998 Sep; 161(5):2284-9. PubMed ID: 9725222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid factors and complex formation. The role of light-chain framework sequences and glycosylation.
    Hay FC; Jones MG; Bond A; Soltys AJ
    Clin Orthop Relat Res; 1991 Apr; (265):54-62. PubMed ID: 1901258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of rheumatoid factors of rheumatoid arthritis patients, of individuals with mycobacterial infections and of normal controls: evidence for maturation in the absence of an autoimmune response.
    Djavad N; Bas S; Shi X; Schwager J; Jeannet M; Vischer T; Roosnek E
    Eur J Immunol; 1996 Oct; 26(10):2480-6. PubMed ID: 8898963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid factor.
    Chen PP; Fong S; Carson DA
    Rheum Dis Clin North Am; 1987 Dec; 13(3):545-68. PubMed ID: 3324205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable region gene usage of human monoclonal rheumatoid factors derived from healthy donors following immunization.
    Thompson KM; Randen I; Børretzen M; Førre O; Natvig JB
    Eur J Immunol; 1994 Aug; 24(8):1771-8. PubMed ID: 8056036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal rheumatoid factor derived from rheumatoid synovial cells monospecific for rabbit IgG.
    Wong A; Kenny T; Ermel R; Robbins D
    J Rheumatol; 1993 Apr; 20(4):623-9. PubMed ID: 8496854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM rheumatoid factors react with human class I HLA molecules.
    Williams RC; Malone CC; Kao KJ
    J Immunol; 1996 Feb; 156(4):1684-94. PubMed ID: 8568276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing of the rheumatoid factor (RF) V gene repertoire in rheumatoid arthritis (RA) by hybridoma clones.
    Natvig JB; Randen I; Thompson K; Førre O; Mageed RA; Jefferis R; Carson DA; Tighe H; Pascual V; Victor KD
    Clin Exp Rheumatol; 1990; 8 Suppl 5():75-80. PubMed ID: 2123137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human IgG Fc-binding phage antibodies constructed from synovial fluid CD38+ B cells of patients with rheumatoid arthritis show the imprints of an antigen-dependent process of somatic hypermutation and clonal selection.
    Van Esch WJ; Reparon-Schuijt CC; Hamstra HJ; Van Kooten C; Logtenberg T; Breedveld FC; Verweij CL
    Clin Exp Immunol; 2003 Feb; 131(2):364-76. PubMed ID: 12562401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation.
    Elagib KE; Børretzen M; Jonsson R; Haga HJ; Thoen J; Thompson KM; Natvig JB
    Clin Exp Immunol; 1999 Aug; 117(2):388-94. PubMed ID: 10444275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus.
    Stevenson FK; Longhurst C; Chapman CJ; Ehrenstein M; Spellerberg MB; Hamblin TJ; Ravirajan CT; Latchman D; Isenberg D
    J Autoimmun; 1993 Dec; 6(6):809-25. PubMed ID: 8155258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the relationship of specificity to titre and functional affinity between circulating Ga- and pan-reactive IgM rheumatoid factors in rheumatoid arthritis.
    Milosević-Jovcić N; Cirić D; Hajduković-Dragojlović L; Mircetić V
    Rheumatology (Oxford); 2004 Sep; 43(9):1190-3. PubMed ID: 15238645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.
    Bonagura VR; Artandi SE; Davidson A; Randen I; Agostino N; Thompson K; Natvig JB; Morrison SL
    J Immunol; 1993 Oct; 151(7):3840-52. PubMed ID: 7690818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous RF structures between and within healthy individuals are not related to HLA DRB1*0401.
    Børretzen M; Natvig JB; Thompson KM
    Mol Immunol; 1997; 34(12-13):929-38. PubMed ID: 9464528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.